Accessibility Menu
 
Kodiak Sciences logo

Kodiak Sciences

(NASDAQ) KOD

Current Price$22.26
Market Cap$1.36B
Since IPO (2018)+119%
5 Year-83%
1 Year+593%
1 Month-9%

Kodiak Sciences Financials at a Glance

Market Cap

$1.36B

Revenue (TTM)

$0.00

Net Income (TTM)

$217.34M

EPS (TTM)

$-4.12

P/E Ratio

-5.40

Dividend

$0.00

Beta (Volatility)

2.37 (High)

Price

$22.26

Volume

28,382

Open

$22.59

Previous Close

$22.26

Daily Range

$22.25 - $23.57

52-Week Range

$1.92 - $31.18

KOD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kodiak Sciences

Industry

Biotechnology

Employees

109

CEO

Victor Perlroth, MD, MBA

Headquarters

Palo Alto, CA 94304, US

KOD Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-208%

Return on Capital

-1%

Return on Assets

-100%

Earnings Yield

-18.52%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.36B

Shares Outstanding

61.05M

Volume

28.38K

Short Interest

0.00%

Avg. Volume

756.74K

Financials (TTM)

Gross Profit

$26.71M

Operating Income

$186.85M

EBITDA

$149.50M

Operating Cash Flow

$117.32M

Capital Expenditure

$400.00K

Free Cash Flow

$117.72M

Cash & ST Invst.

$168.07M

Total Debt

$70.34M

Kodiak Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$6.54M

+2.4%

Gross Margin

0.00%

N/A

Market Cap

$1.36B

N/A

Market Cap/Employee

$12.46M

N/A

Employees

109

N/A

Net Income

$61.46M

-39.8%

EBITDA

$54.92M

-47.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$9.84M

-92.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$50.45M

-20.2%

Short Term Debt

$11.75M

+15.3%

Return on Assets

-99.66%

N/A

Return on Invested Capital

-1.26%

N/A

Free Cash Flow

$32.94M

-54.2%

Operating Cash Flow

$32.88M

-55.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OCSOculis Holding AG
$24.86-2.01%
NRIXNurix Therapeutics, Inc.
$14.43-3.28%
EYPTEyePoint Pharmaceuticals, Inc.
$13.23-4.06%
ANABAnaptysBio, Inc.
$62.37-3.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About KOD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.